News & Information

News & Information

News
current position: Home > News Center > Company News

Sungening Won the First Prize in the Industry Final (Biomedicine) of the 16th China Shenzhen Innovation and Entrepreneurship Competition Longgang Division Qualifier & the 4th Longgang Innovation and Entrepreneurship Star Competition!

2024-11-07 17:25:57
times

The Industry Final of the 16th China Shenzhen Innovation and Entrepreneurship Competition has recently concluded. Sungening’s independently developed innovative drug project SG5035 — R&D of an Ultra-long-acting Anti-fungal Innovative Drug participated in the Industry Final (Biomedicine Track, Enterprise Group) of the 16th China Shenzhen Innovation and Entrepreneurship Competition Longgang Division Qualifier and the 4th "Longgang Innovation and Entrepreneurship Star" Competition. After intense competition, the project stood out from numerous entries and eventually won the First Prize.

Sungening owns the global independent intellectual property rights of SG5035. As a Class 1.1 innovative drug belonging to the echinocandin class for anti-invasive Candida infection, SG5035 features the longest half-life globally in its category. It is expected to achieve single-dose administration per treatment course and is poised to become the world’s first oral echinocandin drug. At present, the SG5035 project is in the preclinical research and application stage, with plans for IND dual filing in China and the United States in 2025.



List of Winners | Biomedical Industry - Enterprise Group


1 (1).webp (1)


About the Shenzhen Innovation Competition


2.webp (2)


The 16th China Shenzhen Innovation and Entrepreneurship Competition Longgang Division Qualifier & the 4th "Longgang Innovation and Entrepreneurship Star" Competition (hereinafter referred to as the Shenzhen Innovation Competition or the Competition) is a public-welfare, authoritative innovation and entrepreneurship event hosted by the Shenzhen Municipal Science and Technology Innovation Bureau and the Shenzhen Municipal People’s Government. It adopts a three-tier (national, municipal, and district) linkage mechanism and serves as the advancement channel for qualifiers held by all districts, the Qianhai Administration, and universities.

Guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, the Competition conscientiously implements the spirit of General Secretary Xi Jinping’s important speech at the 40th Anniversary Celebration of the Shenzhen Special Economic Zone, his important instructions on Shenzhen’s work, and all deployments of the municipal People’s Congress and Political Consultative Conference. It seizes major strategic opportunities, including the dual-zone drive, dual-zone synergy, dual-reform demonstration, the development of a pioneer demonstration city for rule of law in socialism with Chinese characteristics, and the construction of a high-level talent hub in the Guangdong-Hong Kong-Macao Greater Bay Area.

Striving to benchmark the highest, best, and optimal standards, the Competition organizes all activities with a more forward-looking vision, higher standards, more practical measures, and more attentive services. It further leverages its brand demonstration effect and functions as a platform for technology transfer and industrialization of achievements, contributing actively to building a globally influential hub for scientific and technological as well as industrial innovation.




Tags

Related news

  • menu
For protecting human health, we focus on the R&D of new drugs to solve unmet clinical needs

Telephone: 0755-28967200

Email: info@sungening.com

Copyright © Sungening Biological Co., Ltd. 粤ICP备2026014977号
Mainly engaged inOral cyclic peptide, PCSK9 inhibitor, innovative drug development, Welcome to inquire!
Technical Support: 华企立方 disclaimer